Table 1 Effects of GCs on the treatment of different subtypes
Parameters | AIDP (n=189) | AMAN (n=62) | P value (two-tailed) |
|---|---|---|---|
Age (years) | 49.88±18.07 | 48.61±17.46 | 0.631 |
Male, n (%) | 123(65.1) | 34(54.9) | 0.174 |
Rural area, n (%) | 125(66.1) | 43(69.4) | 0.756 |
Hughes score on admission (g) | 2.97±0.93 | 3.10±0.88 | 0.451 |
Hughes score at nadir (g) | 3.50±0.89 | 3.71±0.69 | 0.155 |
Neurological symptoms, n (%) | |||
Facial/bulbar paralysis | 86(45.5) | 10(16.1) | <0.001* |
Oculomotor paralysis | 14(7.4) | 3(4.8) | 0.771 |
Paresthesia | 93(49.2) | 20(32.3) | 0.027* |
Hyperreflexia | 11(5.8) | 12(19.3) | 0.004* |
Complication, n (%) | |||
Autonomic dysfunction, n (%) | |||
Hypertension | 38(20.1) | 11(17.7) | 0.854 |
Cardiac arrhythmia | 13(6.9) | 7(11.3) | 0.283 |
Urinary retention | 21(11.1) | 12(19.4) | 0.128 |
Deep venous thrombosis | 7(3.7) | 3(4.8) | 0.712 |
Dyspnoea | 49(25.9) | 10(16.1) | 0.124 |
Pulmonary infection | 28(14.8) | 8(12.9) | 0.836 |
Diabetes | 16(8.5) | 4(6.5) | 0.789 |
Laboratory abnormality, n (%) | |||
Hyponatraemia | 53(28.0) | 13(16.7) | 0.320 |
Hypokalemia | 42(22.2) | 14(22.6) | 1.000 |
Hospital stay (days) | 14.18±8.10 | 15.35±7.29 | 0.221 |
Mechanical ventilation, n (%) | 19(10.1) | 7(11.3) | 0.811 |
Death in hospital stay, n (%) | 1(0.5) | 1(1.6) | 0.434 |
Hughes score at discharge (g) | 2.51±0.98 | 2.84±0.73 | 0.005* |
Hughes score of 3 months after onset (g) | 2.06±1.14 | 2.50±0.80 | <0.001* |